nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant anti-HER2 monoclonal antibody therapy – ready for breast cancer?
|
Perez, E.A. |
|
2001 |
10 |
S3 |
p. 161-163 3 p. |
artikel |
2 |
Biologic variables and prognosis in patients with ductal carcinoma in situ of the breast
|
Silverstein, M.J. |
|
2001 |
10 |
S3 |
p. 39-53 15 p. |
artikel |
3 |
Breast cancer chemoprevention – Quo vadis?
|
Powles, T. |
|
2001 |
10 |
S3 |
p. 58-61 4 p. |
artikel |
4 |
Cosmetic and reconstructive surgery and risk of breast cancer
|
Petit, J.Y. |
|
2001 |
10 |
S3 |
p. 14-18 5 p. |
artikel |
5 |
Economics, quality of life and breast cancer outcomes – is a balance possible?
|
Goodwin, P.J. |
|
2001 |
10 |
S3 |
p. 190-198 9 p. |
artikel |
6 |
Environmental features influencing the epidemiology of breast cancer
|
Boyle, P. |
|
2001 |
10 |
S3 |
p. 1-8 8 p. |
artikel |
7 |
Evaluation of the axilla and current standards of pathological work-up
|
Viale, G. |
|
2001 |
10 |
S3 |
p. 69-73 5 p. |
artikel |
8 |
Features that predict responsiveness to chemotherapy and endocrine therapies
|
Bonetti, M. |
|
2001 |
10 |
S3 |
p. 147-157 11 p. |
artikel |
9 |
Focalized intraoperative irradiation after conservative surgery for early-stage breast cancer
|
Veronesi, U. |
|
2001 |
10 |
S3 |
p. 84-89 6 p. |
artikel |
10 |
From prophylactic mastectomy to treatment of local relapse
|
Petit, J.Y. |
|
2001 |
10 |
S3 |
p. 74-77 4 p. |
artikel |
11 |
How to improve timing and duration of adjuvant chemotherapy
|
Colleoni, M. |
|
2001 |
10 |
S3 |
p. 101-105 5 p. |
artikel |
12 |
Nutrition and breast cancer
|
Key, T.J. |
|
2001 |
10 |
S3 |
p. 9-13 5 p. |
artikel |
13 |
Oestrogen receptors, growth factors and the control of breast cancer
|
Jordan, V.C. |
|
2001 |
10 |
S3 |
p. 27-35 9 p. |
artikel |
14 |
Optimal adjuvant cytotoxic therapy for breast cancer
|
Lohrisch, C. |
|
2001 |
10 |
S3 |
p. 106-113 8 p. |
artikel |
15 |
Optimal dose of chemotherapy in adjuvant treatment of breast cancer
|
Basser, R.L. |
|
2001 |
10 |
S3 |
p. 96-100 5 p. |
artikel |
16 |
Optimal endocrine therapy
|
Pritchard, K.I. |
|
2001 |
10 |
S3 |
p. 114-122 9 p. |
artikel |
17 |
Options for management of the axillary lymph nodes in breast cancer
|
Krontiras, H. |
|
2001 |
10 |
S3 |
p. 62-68 7 p. |
artikel |
18 |
Overview of the US consensus conference on adjuvant therapy for breast cancer
|
Abrams, J.S. |
|
2001 |
10 |
S3 |
p. 139-146 8 p. |
artikel |
19 |
Psychosocial predictors of outcome IV: patients with early-stage breast cancer
|
Butow, P.N. |
|
2001 |
10 |
S3 |
p. 182-189 8 p. |
artikel |
20 |
Quality of life scores predict outcome in metastatic but not in early breast cancer
|
Coates, A.S. |
|
2001 |
10 |
S3 |
p. 164-170 7 p. |
artikel |
21 |
Radiation in the context of multidisciplinary approaches: radiotherapy and locally advanced breast cancer
|
Yarnold, J. |
|
2001 |
10 |
S3 |
p. 78-83 6 p. |
artikel |
22 |
Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11–93
|
Thürlimann, B. |
|
2001 |
10 |
S3 |
p. 130-138 9 p. |
artikel |
23 |
Surgery and staging for ductal carcinoma in situ
|
Wood, W.C. |
|
2001 |
10 |
S3 |
p. 36-38 3 p. |
artikel |
24 |
Systematic review of the relationship between quality of life and survival in cancer patients
|
Porzsolt, F. |
|
2001 |
10 |
S3 |
p. 171-181 11 p. |
artikel |
25 |
Systemic treatments for ductal carcinoma in situ
|
Spittle, M.F. |
|
2001 |
10 |
S3 |
p. 54-57 4 p. |
artikel |
26 |
Targets for immunotherapy in breast cancer
|
Jäger, D. |
|
2001 |
10 |
S3 |
p. 23-26 4 p. |
artikel |
27 |
The emerging role of hormonal ablation as adjuvant therapy in node + and node – pre-/perimenopausal patients
|
Kaufmann, M. |
|
2001 |
10 |
S3 |
p. 123-129 7 p. |
artikel |
28 |
The use of anthracyclines and taxanes for adjuvant therapy of breast cancer
|
Davidson, N.E. |
|
2001 |
10 |
S3 |
p. 90-95 6 p. |
artikel |
29 |
Vaccines in breast cancer
|
Jäger, E. |
|
2001 |
10 |
S3 |
p. 158-160 3 p. |
artikel |
30 |
Women's advocacy groups and research in breast cancer
|
Baum, M. |
|
2001 |
10 |
S3 |
p. 19-22 4 p. |
artikel |